NCT04366999
- Conditions
- Bariatric Surgery Candidate, Body Weight, Digestive System Diseases, +14 more
- Locations
-
- Beijing Friendship Hospital Beijing, Beijing Municipality, China
Clinical trial condition
NAFLD
Explore clinical trials studying NAFLD. Study availability and eligibility vary by location and protocol.
175 public trials
36 recruiting studies
NAFLD trial results
NCT06396871
- Conditions
- Body Weight, Diabetes Mellitus, Digestive System Diseases, +14 more
- Locations
-
- University Study Center for Metabolic Diseases Dresden, Saxony, Germany
NCT06308757
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +15 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
NCT06098417
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +19 more
- Locations
-
- Silvia Palmisano Trieste, Italy
Recruiting
The European NAFLD Registry
NCT04442334
- Conditions
- Adenocarcinoma, Body Weight, Carcinoma, +40 more
- Locations
-
- Universitair Ziekenhuis Antwerpen Antwerp, Belgium
- Helsinki University Hospital Helsinki, Finland
- Le Centre de Recherche Clinique (CRC) du CHU d'Angers Angers, France
- Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière Paris, France
NCT04036357
- Conditions
- Cardiovascular Diseases, Cardiovascular Risk Factor, Digestive System Diseases, +9 more
- Locations
-
- Day Service of Internal Medicine and Metabolic Disorders - Policlinico Umberto I - Sapienza University of Rome Rome, Italy
Not yet recruiting
The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT07740109
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +11 more
- Locations
-
- Liver Clinic of Valiasr Hospital (Tabriz, Iran) Tabriz, Iran
Not yet recruiting
RE and Probiotics in MAFLD/NAFLD
NCT06563921
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
- Locations
-
Not specified
Not yet recruiting
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
NCT03867487
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
- Locations
-
- Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Not yet recruiting
Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
NCT07310407
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- National Hepatology and Tropical Medicine Research Institute (NHTMRI) Cairo, Egypt